Demand for Advanced Molecular Diagnostics to Drive Polymerase Chain Reaction Market to USD 8.6 Billion by 2020

The global PCR market is estimated to reach USD 8.6 Billion in 2020, growing at a CAGR of 4.2% from 2016 to 2020, according to a new market research report Polymerase Chain Reaction (PCR) Market – Global PCR Systems and Applications Analysis and Forecast 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the Polymerase Chain Reaction (PCR) Market – Global PCR Systems and Applications Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/polymerase-chain-reaction-market/

PCR technology is being used routinely in life sciences research, clinical applications and biopharmaceutical companies for rapid and highly specific diagnosis of infectious diseases, including those caused by bacteria or viruses and biotherapeutic product development. PCR also allows early diagnosis of malignant diseases such as leukemia and lymphomas, at a higher sensitivity and specificity than many other available molecular diagnostic methods. The global PCR market report estimates the market size (Revenue USD million - 2013 to 2020) and composition of this market and also forecasts growth trends (CAGR% - 2016 to 2020). It also covers the major companies operating in the market and provides detailed market analysis of the different PCR systems such as standard, real-time and digital PCR machines available in the global market.

The global PCR market is segmented as:

1. PCR Systems/Instrument
1.1. Instruments
1.1.1. Standard PCR Systems
1.1.2. Real Time PCR Systems
1.1.3. Digital PCR Systems
1.2. Reagents and Consumables

2. Application
2.1. Clinical Diagnostics
2.2. Life Sciences Research
2.3. Others

3. End User
3.1. Academic and Research Organizations
3.2. Clinical Diagnostics Labs and Hospitals
3.3. Pharmaceutical and Biotechnology Industries

4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World

5. Company Profiles
5.1. Abbott Laboratories
5.2. Affymetrix, Inc.
5.3. Agilent Technologies, Inc.
5.4. Becton, Dickinson & Company
5.5. Bio-Rad Laboratories, Inc.
5.6. Danaher Corporation (Beckman Coulter, Inc.)
5.7. F. Hoffmann-La Roche Ltd.
5.8. GE Healthcare
5.9. Qiagen
5.10. Sigma-Aldrich Co. LLC.
5.11. Thermo Fisher Scientific, Inc.

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.